These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6486500)

  • 1. Halothane-induced changes in the release and disposition of norepinephrine at adrenergic nerve endings in dog saphenous vein.
    Lunn JJ; Rorie DK
    Anesthesiology; 1984 Oct; 61(4):377-84. PubMed ID: 6486500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered release and metabolism of norepinephrine in superfused canine saphenous veins in the presence of halothane and hypoxia.
    Kamath GS; Rorie DK; Tyce GM
    Anesthesiology; 1993 Mar; 78(3):553-61. PubMed ID: 8457054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypoxia on norepinephrine release and metabolism in dog pulmonary artery.
    Rorie DK; Tyce GM
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Sep; 55(3):750-8. PubMed ID: 6629911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that halothane inhibits norepinephrine release from sympathetic nerve endings in dog saphenous vein by stimulation of presynaptic inhibitory muscarinic receptors.
    Rorie DK; Tyce GM; Mackenzie RA
    Anesth Analg; 1984 Dec; 63(12):1059-64. PubMed ID: 6507906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venomotor changes caused by halothane acting on the sympathetic nerves.
    Muldoon SM; Vanhoutte PM; Lorenz RR; Van Dyke RA
    Anesthesiology; 1975 Jul; 43(1):41-8. PubMed ID: 238434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estradiol on release and disposition of norepinephrine from nerve endings.
    Hamlet MA; Rorie DK; Tyce GM
    Am J Physiol; 1980 Oct; 239(4):H450-H456. PubMed ID: 6252789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halothane decreases the release of neuropeptide Y and 3,4-dihydroxyphenylglycol from superfused segments of dog pulmonary artery.
    Rorie DK; Hunter LW; Lunn JJ
    Anesthesiology; 1990 Oct; 73(4):722-30. PubMed ID: 2221441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of norepinephrine during nerve stimulation in dog saphenous vein.
    Rorie DK; Muldoon SM; Tyce GM
    Am J Physiol; 1980 Aug; 239(2):H238-46. PubMed ID: 7406060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of norepinephrine- 3 H release from sympathetic nerve endings in veins by acetylcholine.
    Vanhoutte PM; Lorenz RR; Tyce GM
    J Pharmacol Exp Ther; 1973 May; 185(2):386-94. PubMed ID: 4703828
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of acetylstrophanthidin and ouabain on the sympathetic adrenergic neuroeffector junction in canine vascular smooth muscle.
    Lorenz RR; Powis DA; Vanhoutte PM; Shepherd JT
    Circ Res; 1980 Dec; 47(6):845-54. PubMed ID: 7438335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroxyphenylglycol as an index of neuronal uptake in dog saphenous vein.
    Rorie DK; Hunter LW; Tyce GM
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1945-51. PubMed ID: 2603979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of lithium on the adrenergic nerve ending.
    Beaty O; Collis MG; Shepherd JT
    J Pharmacol Exp Ther; 1981 Aug; 218(2):309-17. PubMed ID: 6265622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Ca antagonists on the norepinephrine release and contractile responses of isolated canine saphenous veins to transmural nerve stimulation.
    Takata Y; Kato H
    Jpn J Pharmacol; 1984 Apr; 34(4):397-409. PubMed ID: 6727076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of adrenergic neurotransmission in isolated veins of the dog by potassium ions.
    Lorenz RR; Vanhoutte PM
    J Physiol; 1975 Mar; 246(2):479-500. PubMed ID: 167162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fentanyl on adrenergic function in canine coronary arteries.
    Rorie DK; Muldoon SM; Tyce GM
    Anesth Analg; 1981 Jan; 60(1):21-7. PubMed ID: 7192945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine content and disposition in large and small pulmonary artery of dog.
    Rorie DK; Tyce GM
    Am J Physiol; 1983 Jul; 245(1):H104-9. PubMed ID: 6869551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of endogenous norepinephrine overflow from canine saphenous veins.
    Muldoon SM; Tyce GM; Moyer TP; Rorie DK
    Am J Physiol; 1979 Feb; 236(2):H263-7. PubMed ID: 420310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitroprusside on smooth muscle and adrenergic nerve terminals in isolated blood vessels.
    Verhaeghe RH; Shepherd JT
    J Pharmacol Exp Ther; 1976 Oct; 199(1):269-77. PubMed ID: 978482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue accumulation and release of newly synthesized 3H-dopamine and 3H-noradrenaline in canine saphenous veins incubated with 3H-(--)-tyrosine.
    Boels PJ; Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):7-14. PubMed ID: 6633679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.